VYF-13402-51431
3 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 200 / DC
- Registered
- 2022-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
5T2-10967-77190
Child or adolescent in my care · Male · 2022-01-19
Timeline
-
2021-03-20
Dose 1 — Moderna
-
2021-04-17
Dose 2 — Moderna
-
2022-01-19
Registered in v-safe
-
2022-01-19
Dose 3 — Moderna
- 2022-01-19
-
2022-01-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
- 2022-01-21
- 2022-01-22
- 2022-01-23
- 2022-01-24
- 2022-01-25
- 2022-01-28
- 2022-02-04
- 2022-02-09
- 2022-02-19
- 2022-02-23
-
2022-03-04
Survey response — day 42, dose 3MedDRA: Headache, Rhinorrhoea — Feeling: FairFree text: Headache Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-04-20
- 2022-07-22
- 2023-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-20 | Moderna | No |
| 2 | 2021-04-17 | Moderna | No |
| 3 | 2022-01-19 | Moderna | No |
Free text
Release 11 — day 42, dose 3
Symptoms: Headache Runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release